ESTA

Establishment Labs Holdings Inc. NASDAQ

Healthcare ·Medical - Devices ·CR · establishmentlabs.com

$70.24

Pre-mkt $71.36 +1.59%

Mkt Cap $2.1B

52w Low $32.25 74.4% of range 52w High $83.31

50d MA $65.77 200d MA $57.81

P/E (TTM) -40.8x

EV/EBITDA -71.7x

P/B 88.3x

Debt/Equity 11.2x

ROE -216.9%

P/FCF -37.9x

RSI (14) —

ATR (14) —

Beta 1.08

50d MA $65.77

200d MA $57.81

Avg Volume 496.9K

About

Establishment Labs Holdings Inc., a medical technology company, manufactures and markets medical devices for aesthetic and reconstructive plastic surgery. The company primarily offers silicone gel-filled breast implants under Motiva Implants brand name. It also provides Motiva Ergonomix and Motiva Ergonomix2 gravity sensitive round soft silicone-gel-filled breast implants; and Motiva Flora Tissue …

Recent Earnings

Date	Time	Est	Rptd	Surp	Base	Gap%	D1%	D2%	D3%	D4%	D5%	Guide ▲★
Feb 24, 2026	AMC	-0.21	-0.09	+58.1%	79.67	+0.3%	-1.7%	-3.2%	-1.2%	-4.5%	-10.7%	—
Nov 5, 2025	AMC	-0.54	-0.38	+29.6%	60.51	+1.6%	+7.3%	+7.4%	+11.9%	+13.1%	+4.4%	—
Aug 7, 2025	AMC	-0.54	-0.57	-5.6%	35.96	-0.3%	-3.2%	-6.5%	-6.5%	+6.6%	+5.5%	—
May 7, 2025	AMC	-0.83	-0.70	+15.7%	33.27	+4.4%	+4.6%	+2.0%	+3.9%	+5.1%	+9.6%	—
Feb 26, 2025	AMC	-0.64	-0.98	-53.1%	36.06	+5.4%	+17.9%	+18.9%	+18.9%	+28.1%	+20.9%	—
Nov 7, 2024	AMC	-0.61	-0.59	+3.3%	48.12	-11.4%	-3.9%	-5.9%	-11.9%	-18.3%	-22.0%	—
Aug 6, 2024	AMC	-0.51	-0.62	-21.6%	36.53	-7.8%	-2.7%	+6.7%	+13.6%	+12.3%	+16.0%	—
May 8, 2024	AMC	-0.67	-0.58	+13.4%	51.25	+6.1%	+10.9%	+9.2%	+9.6%	+14.8%	+16.8%	—
Feb 28, 2024	AMC	-0.91	-0.79	+13.2%	38.46	+19.6%	+18.8%	+14.7%	+23.4%	+19.7%	+28.1%	—
Nov 7, 2023	AMC	-0.80	-1.12	-40.0%	32.70	-36.5%	-23.2%	-30.3%	-33.7%	-32.6%	-21.1%	—
Aug 8, 2023	AMC	-0.72	-0.65	+9.7%	61.28	+1.2%	-5.3%	-7.1%	-9.0%	-7.2%	-8.3%	—
May 8, 2023	AMC	-0.68	-0.48	+29.4%	67.69	-2.2%	+1.8%	+5.6%	+3.6%	-1.6%	+1.8%	—

Recent Analyst Ratings

Date	Firm	Action	Grade	Target	Base	Open	Gap%	D1%	D2%	D3%	D4%	D5%
Apr 29	BTIG	Maintains	Buy → Buy	—	$64.40	$64.12	-0.4%	-3.1%	+6.6%	+9.1%	—	—
Mar 11	Citigroup	Maintains	Neutral → Neutral	—	$66.35	$66.36	+0.0%	-0.2%	-4.1%	-4.5%	-4.3%	-2.0%
Feb 26	Canaccord Genuity	Maintains	Buy → Buy	—	$78.29	$78.00	-0.4%	-1.5%	+0.5%	-2.8%	-9.2%	-9.1%
Feb 25	Stephens & Co.	Maintains	Overweight → Overweight	—	$79.67	$79.90	+0.3%	-1.7%	-3.2%	-1.2%	-4.5%	-10.7%
Feb 25	Mizuho	Maintains	Outperform → Outperform	—	$79.67	$79.90	+0.3%	-1.7%	-3.2%	-1.2%	-4.5%	-10.7%
Feb 24	Needham	Maintains	Buy → Buy	—	$74.96	$66.47	-11.3%	+6.3%	+4.4%	+2.9%	+5.0%	+1.5%
Feb 24	BTIG	Maintains	Buy → Buy	—	$74.96	$66.47	-11.3%	+6.3%	+4.4%	+2.9%	+5.0%	+1.5%
Jan 12	Needham	Maintains	Buy → Buy	—	$68.34	$71.88	+5.2%	-2.3%	-4.7%	-3.1%	-3.5%	-1.2%
Dec 31	BTIG	Maintains	Buy → Buy	—	$72.92	$74.47	+2.1%	-0.1%	-5.6%	-8.9%	-4.9%	-4.0%
Dec 17	Mizuho	Maintains	Outperform → Outperform	—	$74.15	$74.10	-0.1%	+0.8%	-6.1%	+0.4%	+3.3%	+2.7%
Dec 17	Canaccord Genuity	Maintains	Buy → Buy	—	$74.15	$74.10	-0.1%	+0.8%	-6.1%	+0.4%	+3.3%	+2.7%
Dec 17	JP Morgan	Maintains	Overweight → Overweight	—	$74.15	$74.10	-0.1%	+0.8%	-6.1%	+0.4%	+3.3%	+2.7%
Dec 11	Citigroup	Maintains	Neutral → Neutral	—	$72.46	$72.98	+0.7%	+0.4%	+0.1%	-0.6%	+2.3%	+3.1%
Dec 10	Needham	Maintains	Buy → Buy	—	$71.01	$72.88	+2.6%	+2.0%	+2.4%	+2.1%	+1.4%	+4.4%
Nov 14	BTIG	Maintains	Buy → Buy	—	$64.75	$64.06	-1.1%	-1.2%	+1.7%	-0.3%	+3.2%	+2.0%
Nov 6	Canaccord Genuity	Maintains	Buy → Buy	—	$60.51	$61.45	+1.6%	+7.3%	+7.4%	+11.9%	+13.1%	+4.4%
Nov 6	Mizuho	Maintains	Outperform → Outperform	—	$60.51	$61.45	+1.6%	+7.3%	+7.4%	+11.9%	+13.1%	+4.4%
Nov 6	Needham	Maintains	Buy → Buy	—	$60.51	$61.45	+1.6%	+7.3%	+7.4%	+11.9%	+13.1%	+4.4%
Nov 6	JP Morgan	Maintains	Overweight → Overweight	—	$60.51	$61.45	+1.6%	+7.3%	+7.4%	+11.9%	+13.1%	+4.4%
Nov 5	BTIG	Maintains	Buy → Buy	—	$49.40	$53.91	+9.1%	+22.5%	+31.4%	+31.6%	+37.0%	+38.6%
Jul 16	Mizuho	Maintains	Outperform → Outperform	—	$44.42	$45.12	+1.6%	-1.7%	-4.4%	-6.4%	-4.1%	-2.1%
Jul 9	Citigroup	Maintains	Neutral → Neutral	—	$43.97	$44.08	+0.3%	+2.5%	+4.5%	+2.1%	+3.5%	+1.0%
Jun 13	Needham	Maintains	Buy → Buy	—	$37.12	$36.04	-2.9%	+0.9%	+4.8%	+0.8%	+2.5%	+1.9%
May 14	Needham	Upgrade	Hold → Buy	—	$34.96	$36.41	+4.1%	+4.3%	+4.7%	+3.4%	+5.3%	+7.7%
Mar 6	Stephens & Co.	Maintains	Overweight → Overweight	—	$43.60	$42.63	-2.2%	-3.5%	-4.4%	-15.8%	-17.9%	-12.7%
Feb 27	Stephens & Co.	Maintains	Overweight → Overweight	—	$36.06	$38.00	+5.4%	+17.9%	+18.9%	+18.9%	+28.1%	+20.9%
Oct 14	BTIG	Maintains	Buy → Buy	—	$39.83	$40.42	+1.5%	+3.6%	+6.8%	+7.7%	+6.2%	+5.2%
Oct 1	Citigroup	Maintains	Neutral → Neutral	—	$43.27	$43.00	-0.6%	-6.3%	+3.2%	-3.4%	+4.6%	+6.8%
Aug 22	Citigroup	Maintains	Neutral → Neutral	—	$44.05	$44.40	+0.8%	-1.6%	+3.6%	+4.6%	+5.0%	+4.9%
Aug 7	JP Morgan	Maintains	Overweight → Overweight	—	$36.53	$33.69	-7.8%	-2.7%	+6.7%	+13.6%	+12.3%	+16.0%
Aug 7	Stephens & Co.	Maintains	Overweight → Overweight	—	$36.53	$33.69	-7.8%	-2.7%	+6.7%	+13.6%	+12.3%	+16.0%
Jul 10	Citigroup	Maintains	Neutral → Neutral	—	$44.29	$44.50	+0.5%	-2.2%	+3.0%	+1.4%	+2.8%	+10.6%
Jun 6	Mizuho	Maintains	Buy → Buy	—	$53.89	$54.51	+1.2%	-4.0%	-10.7%	-10.1%	-13.5%	-12.0%
May 22	Citigroup	Downgrade	Buy → Neutral	—	$54.37	$52.64	-3.2%	-2.0%	-2.3%	-1.5%	-2.4%	-4.9%
Apr 3	Citigroup	Maintains	Buy → Buy	—	$50.45	$50.95	+1.0%	+4.6%	+4.5%	+7.4%	+7.4%	+9.8%
Apr 1	Mizuho	Maintains	Buy → Buy	—	$50.90	$52.13	+2.4%	-4.1%	-0.9%	+3.7%	+3.5%	+6.4%
Mar 12	TD Cowen	Maintains	Outperform → Outperform	—	$48.73	$49.88	+2.4%	+2.7%	+3.5%	-0.9%	+0.6%	+4.0%
Feb 29	JP Morgan	Maintains	Overweight → Overweight	—	$38.46	$45.99	+19.6%	+18.8%	+14.7%	+23.4%	+19.7%	+28.1%
Jan 11	Stephens & Co.	Maintains	Overweight → Overweight	—	$31.68	$31.51	-0.5%	+7.6%	+11.9%	+9.6%	+9.2%	+14.0%
Nov 9	B. Riley Securities	Maintains	Buy → Buy	—	$25.11	$26.50	+5.5%	-9.3%	-13.7%	-12.2%	+2.8%	-7.3%
Nov 8	Mizuho	Maintains	Buy → Buy	—	$32.70	$20.75	-36.5%	-23.2%	-30.3%	-33.7%	-32.6%	-21.1%
Nov 8	TD Cowen	Maintains	Outperform → Outperform	—	$32.70	$20.75	-36.5%	-23.2%	-30.3%	-33.7%	-32.6%	-21.1%
Jul 21	Stephens & Co.	Maintains	Overweight → Overweight	—	$68.83	$69.67	+1.2%	+2.3%	+1.9%	+0.8%	-0.4%	+2.2%
Apr 21	Mizuho	Maintains	Buy → Buy	—	$74.92	$75.94	+1.4%	-0.0%	-2.1%	-3.9%	-5.5%	-8.6%
Apr 21	Stephens & Co.	Maintains	Overweight → Overweight	—	$74.92	$75.94	+1.4%	-0.0%	-2.1%	-3.9%	-5.5%	-8.6%
Apr 17	BTIG	Maintains	Buy → Buy	—	$73.27	$73.99	+1.0%	+1.9%	+2.3%	+3.6%	+2.3%	+2.2%
Feb 28	Stephens & Co.	Maintains	Overweight → Overweight	—	$67.04	$68.64	+2.4%	+6.9%	+8.8%	+4.3%	+9.9%	+11.1%
Jan 24	Mizuho	Maintains	Buy → Buy	—	$68.21	$68.86	+1.0%	-1.2%	+0.3%	-1.2%	-3.2%	-1.5%
Dec 28	Stephens & Co.	Maintains	Overweight → Overweight	—	$60.12	$59.89	-0.4%	+0.5%	+7.9%	+9.2%	+4.3%	+8.2%
Oct 13	Mizuho	Maintains	Buy → Buy	—	$55.96	$56.47	+0.9%	+2.7%	-0.3%	+2.2%	+0.7%	-8.6%

Recent Filings

8-K · 1.01 ! Medium

Establishment Labs Holdings Inc. -- 8-K 1.01: Financing / Debt Agreement

Establishment Labs secured $259 million in amended credit facilities, strengthening its balance sheet and providing capital for operations and growth initiatives.

Apr 30

8-K

Establishment Labs Holdings Inc. -- 8-K Filing

Establishment Labs reported 2025 financial results and issued 2026 guidance, providing investors with updated performance metrics and forward-looking projections for the medical device company.

Feb 24

Data updated apr 25, 2026 7:46am · Source: massive.com